Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,710 | 2,435 | 2,271 | 3,259 | 2,584 |
| Receivables | 145 | 186 | 383 | 1,195 | 777 |
| Other current assets | 792 | 1,132 | 856 | 1,090 | 1,601 |
| TOTAL | $2,793 | $4,089 | $4,265 | $6,070 | $5,547 |
| Non-Current Assets | |||||
| PPE Net | 689 | 928 | 2,489 | 2,822 | 3,365 |
| Intangibles | 0 | 0 | 0 | 696 | 687 |
| Other Non-Current Assets | 1,572 | 1,773 | 4,260 | 4,537 | 5,320 |
| TOTAL | $2,261 | $2,701 | $6,749 | $8,055 | $9,372 |
| Total Assets | $5,054 | $6,790 | $11,014 | $14,125 | $14,919 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,724 | 1,620 | 1,990 | 2,739 | 1,000 |
| Accounts payable and accrued liabilities | 275 | 397 | 787 | 835 | 335 |
| Accrued Expenses | 615 | 501 | 473 | 1,078 | 772 |
| Other current liabilities | 154 | 233 | 286 | 419 | 171 |
| TOTAL | $2,930 | $3,195 | $4,352 | $6,095 | $3,532 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,625 | 1,625 | N/A | N/A | 1,987 |
| Deferred Revenues | 120 | 377 | 383 | 460 | 743 |
| Other Non-Current Liabilities | 0 | 29 | 2,797 | 2,917 | 3,017 |
| TOTAL | $1,629 | $1,664 | $2,813 | $2,939 | $5,042 |
| Total Liabilities | $4,559 | $4,859 | $7,165 | $9,034 | $8,574 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5 | 5 | 5 | 5 | 5 |
| Common Shares | 15 | 15 | 15 | 14 | 14 |
| Retained earnings | -136,187 | -134,706 | -132,675 | -131,457 | -130,156 |
| Other shareholders' equity | -214 | -215 | -291 | -187 | -208 |
| TOTAL | $495 | $1,931 | $3,849 | $5,091 | $6,345 |
| Total Liabilities And Equity | $5,054 | $6,790 | $11,014 | $14,125 | $14,919 |